Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma.

Skubitz KM, Wilson JD, Cheng EY, Lindgren BR, Boylan KLM, Skubitz APN.

J Transl Med. 2019 Apr 18;17(1):130. doi: 10.1186/s12967-019-1883-6.

2.

Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection.

Skubitz APN, Boylan KLM, Geschwind K, Cao Q, Starr TK, Geller MA, Celestino J, Bast RC Jr, Lu KH, Koopmeiners JS.

Cancer Prev Res (Phila). 2019 Mar;12(3):171-184. doi: 10.1158/1940-6207.CAPR-18-0221. Epub 2019 Feb 1.

PMID:
30709840
3.

Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.

Uppendahl LD, Felices M, Bendzick L, Ryan C, Kodal B, Hinderlie P, Boylan KLM, Skubitz APN, Miller JS, Geller MA.

Gynecol Oncol. 2019 Apr;153(1):149-157. doi: 10.1016/j.ygyno.2019.01.006. Epub 2019 Jan 15.

PMID:
30658847
4.

Development of a multiplexed giant magnetoresistive biosensor array prototype to quantify ovarian cancer biomarkers.

Klein T, Wang W, Yu L, Wu K, Boylan KLM, Vogel RI, Skubitz APN, Wang JP.

Biosens Bioelectron. 2019 Feb 1;126:301-307. doi: 10.1016/j.bios.2018.10.046. Epub 2018 Oct 23.

PMID:
30445305
5.

Evaluating the potential of residual Pap test fluid as a resource for the metaproteomic analysis of the cervical-vaginal microbiome.

Afiuni-Zadeh S, Boylan KLM, Jagtap PD, Griffin TJ, Rudney JD, Peterson ML, Skubitz APN.

Sci Rep. 2018 Jul 18;8(1):10868. doi: 10.1038/s41598-018-29092-4.

6.

A multiplex platform for the identification of ovarian cancer biomarkers.

Boylan KLM, Geschwind K, Koopmeiners JS, Geller MA, Starr TK, Skubitz APN.

Clin Proteomics. 2017 Oct 10;14:34. doi: 10.1186/s12014-017-9169-6. eCollection 2017.

7.

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.

Felices M, Chu S, Kodal B, Bendzick L, Ryan C, Lenvik AJ, Boylan KLM, Wong HC, Skubitz APN, Miller JS, Geller MA.

Gynecol Oncol. 2017 Jun;145(3):453-461. doi: 10.1016/j.ygyno.2017.02.028. Epub 2017 Feb 22.

8.

Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.

Buchanan PC, Boylan KLM, Walcheck B, Heinze R, Geller MA, Argenta PA, Skubitz APN.

J Biol Chem. 2017 Apr 14;292(15):6339-6351. doi: 10.1074/jbc.M116.746859. Epub 2017 Feb 23.

9.

The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.

Boylan KL, Buchanan PC, Manion RD, Shukla DM, Braumberger K, Bruggemeyer C, Skubitz AP.

Oncotarget. 2017 Feb 7;8(6):9717-9738. doi: 10.18632/oncotarget.14206.

10.

Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors.

Skubitz KM, Geschwind K, Xu WW, Koopmeiners JS, Skubitz AP.

J Transl Med. 2016 Feb 13;14:51. doi: 10.1186/s12967-016-0802-3.

11.

A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics.

Boylan KL, Afiuni-Zadeh S, Geller MA, Hickey K, Griffin TJ, Pambuccian SE, Skubitz AP.

Clin Proteomics. 2014 Jul 14;11(1):30. doi: 10.1186/1559-0275-11-30. eCollection 2014.

12.

Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.

Skubitz KM, Skubitz AP, Xu WW, Luo X, Lagarde P, Coindre JM, Chibon F.

J Transl Med. 2014 Jun 20;12:176. doi: 10.1186/1479-5876-12-176.

13.

Storage of human biospecimens: selection of the optimal storage temperature.

Hubel A, Spindler R, Skubitz AP.

Biopreserv Biobank. 2014 Jun;12(3):165-75. doi: 10.1089/bio.2013.0084. Epub 2014 Jun 11. Review.

PMID:
24918763
14.

Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity.

Misemer BS, Skubitz AP, Carlos Manivel J, Schmechel SC, Cheng EY, Henriksen JC, Koopmeiners JS, Corless CL, Skubitz KM.

Cancer Med. 2014 Feb;3(1):81-90. doi: 10.1002/cam4.160. Epub 2013 Nov 26.

15.

Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.

Skubitz AP, Taras EP, Boylan KL, Waldron NN, Oh S, Panoskaltsis-Mortari A, Vallera DA.

Gynecol Oncol. 2013 Sep;130(3):579-87. doi: 10.1016/j.ygyno.2013.05.027. Epub 2013 May 27.

16.

Isothermal vitrification methodology development for non-cryogenic storage of archival human sera.

Less R, Boylan KL, Skubitz AP, Aksan A.

Cryobiology. 2013 Apr;66(2):176-85. doi: 10.1016/j.cryobiol.2013.01.003. Epub 2013 Jan 24.

17.

Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors.

Sueblinvong T, Ghebre R, Iizuka Y, Pambuccian SE, Isaksson Vogel R, Skubitz AP, Bazzaro M.

PLoS One. 2012;7(11):e50519. doi: 10.1371/journal.pone.0050519. Epub 2012 Nov 30.

18.

Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.

Betsou F, Gunter E, Clements J, DeSouza Y, Goddard KA, Guadagni F, Yan W, Skubitz A, Somiari S, Yeadon T, Chuaqui R.

J Mol Diagn. 2013 Jan;15(1):3-16. doi: 10.1016/j.jmoldx.2012.06.008. Epub 2012 Nov 27. Review.

19.

Short-term stability study of RNA at room temperature.

Mathay C, Yan W, Chuaqui R, Skubitz AP, Jeon JP, Fall N, Betsou F, Barnes M; ISBER Biospecimen Science Working Group.

Biopreserv Biobank. 2012 Dec;10(6):532-42. doi: 10.1089/bio.2012.0030.

PMID:
24845140
20.

Stabilization of tissue specimens for pathological examination and biomedical research.

Unhale SA, Skubitz AP, Solomon R, Hubel A.

Biopreserv Biobank. 2012 Dec;10(6):493-500. doi: 10.1089/bio.2012.0031. Review.

PMID:
24845135
21.

Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC).

Lehmann S, Guadagni F, Moore H, Ashton G, Barnes M, Benson E, Clements J, Koppandi I, Coppola D, Demiroglu SY, DeSouza Y, De Wilde A, Duker J, Eliason J, Glazer B, Harding K, Jeon JP, Kessler J, Kokkat T, Nanni U, Shea K, Skubitz A, Somiari S, Tybring G, Gunter E, Betsou F; International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science.

Biopreserv Biobank. 2012 Aug;10(4):366-74. doi: 10.1089/bio.2012.0012.

22.

Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.

Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ, Schmechel SC.

Diagn Pathol. 2012 Jun 20;7:42. doi: 10.1186/1746-1596-7-42.

23.

Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research.

Campbell LD, Betsou F, Garcia DL, Giri JG, Pitt KE, Pugh RS, Sexton KC, Skubitz AP, Somiari SB.

Biopreserv Biobank. 2012 Apr;10(2):232-3. doi: 10.1089/bio.2012.1025. No abstract available.

PMID:
24844910
24.

The ISBER Best Practices: Insight from the Editors of the Third Edition.

Vaught J, Campbell LD, Betsou F, Garcia DL, Pugh RS, Sexton KC, Skubitz AP.

Biopreserv Biobank. 2012 Apr;10(2):76-8. doi: 10.1089/bio.2012.1024. No abstract available.

PMID:
24844903
25.

Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas.

Skubitz KM, Francis P, Skubitz AP, Luo X, Nilbert M.

Cancer. 2012 Sep 1;118(17):4235-43. doi: 10.1002/cncr.26733. Epub 2012 Jan 17.

26.

Mathematical prognostic biomarker models for treatment response and survival in epithelial ovarian cancer.

Nikas JB, Boylan KL, Skubitz AP, Low WC.

Cancer Inform. 2011;10:233-47. doi: 10.4137/CIN.S8104. Epub 2011 Oct 3.

27.

State of the art in preservation of fluid biospecimens.

Hubel A, Aksan A, Skubitz AP, Wendt C, Zhong X.

Biopreserv Biobank. 2011 Sep;9(3):237-44. doi: 10.1089/bio.2010.0034.

PMID:
24850337
28.

Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.

Boylan KL, Misemer B, De Rycke MS, Andersen JD, Harrington KM, Kalloger SE, Gilks CB, Pambuccian SE, Skubitz AP.

Int J Mol Sci. 2011 Feb 22;12(2):1334-58. doi: 10.3390/ijms12021334.

29.

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.

Derycke MS, Pambuccian SE, Gilks CB, Kalloger SE, Ghidouche A, Lopez M, Bliss RL, Geller MA, Argenta PA, Harrington KM, Skubitz AP.

Am J Clin Pathol. 2010 Nov;134(5):835-45. doi: 10.1309/AJCPGXK0FR4MHIHB.

30.

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.

Andersen JD, Boylan KL, Jemmerson R, Geller MA, Misemer B, Harrington KM, Weivoda S, Witthuhn BA, Argenta P, Vogel RI, Skubitz AP.

J Ovarian Res. 2010 Sep 10;3:21. doi: 10.1186/1757-2215-3-21.

31.

Two new synthetic peptides from the N-domain of CEACAM1 (CD66a) stimulate neutrophil adhesion to endothelial cells.

Skubitz KM, Skubitz AP.

Biopolymers. 2011;96(1):25-31. doi: 10.1002/bip.21447.

PMID:
20560140
32.

Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.

Boylan KL, Andersen JD, Anderson LB, Higgins L, Skubitz AP.

Proteome Sci. 2010 Jun 14;8:31. doi: 10.1186/1477-5956-8-31.

33.

Standard preanalytical coding for biospecimens: defining the sample PREanalytical code.

Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, DeSouza Y, Eliason J, Glazer B, Guadagni F, Harding K, Horsfall DJ, Kleeberger C, Nanni U, Prasad A, Shea K, Skubitz A, Somiari S, Gunter E; International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1004-11. doi: 10.1158/1055-9965.EPI-09-1268. Epub 2010 Mar 23.

34.

Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis.

Andersen JD, Boylan KL, Xue FS, Anderson LB, Witthuhn BA, Markowski TW, Higgins L, Skubitz AP.

Electrophoresis. 2010 Jan;31(4):599-610. doi: 10.1002/elps.200900441.

35.

S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.

DeRycke MS, Andersen JD, Harrington KM, Pambuccian SE, Kalloger SE, Boylan KL, Argenta PA, Skubitz AP.

Am J Clin Pathol. 2009 Dec;132(6):846-56. doi: 10.1309/AJCPTK87EMMIKPFS.

36.

Human biospecimen research: experimental protocol and quality control tools.

Betsou F, Barnes R, Burke T, Coppola D, Desouza Y, Eliason J, Glazer B, Horsfall D, Kleeberger C, Lehmann S, Prasad A, Skubitz A, Somiari S, Gunter E; [International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science].

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1017-25. doi: 10.1158/1055-9965.EPI-08-1231. Epub 2009 Mar 31. Review. No abstract available.

37.

Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells.

Skubitz KM, Skubitz AP.

J Transl Med. 2008 Dec 10;6:78. doi: 10.1186/1479-5876-6-78.

38.

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.

Skubitz KM, Pambuccian S, Manivel JC, Skubitz AP.

J Transl Med. 2008 May 6;6:23. doi: 10.1186/1479-5876-6-23.

39.

Early detection of ovarian cancer using group biomarkers.

Tchagang AB, Tewfik AH, DeRycke MS, Skubitz KM, Skubitz AP.

Mol Cancer Ther. 2008 Jan;7(1):27-37. doi: 10.1158/1535-7163.MCT-07-0565. Epub 2008 Jan 9.

40.

Differential gene expression identifies subgroups of ovarian carcinoma.

Skubitz AP, Pambuccian SE, Argenta PA, Skubitz KM.

Transl Res. 2006 Nov;148(5):223-48.

PMID:
17145569
41.

Differential gene expression identifies subgroups of renal cell carcinoma.

Skubitz KM, Zimmermann W, Kammerer R, Pambuccian S, Skubitz AP.

J Lab Clin Med. 2006 May;147(5):250-67. Erratum in: J Lab Clin Med. 2007 Mar;149(3):163. Zimmerman, Wolfgang [corrected to Zimmermann, Wolfgang].

PMID:
16697773
42.

Disaggregation and invasion of ovarian carcinoma ascites spheroids.

Burleson KM, Boente MP, Pambuccian SE, Skubitz AP.

J Transl Med. 2006 Jan 24;4:6.

43.

Protein kinase activity is associated with CD63 in melanoma cells.

Iida J, Skubitz AP, McCarthy JB, Skubitz KM.

J Transl Med. 2005 Nov 30;3:42.

44.

Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Burleson KM, Hansen LK, Skubitz AP.

Clin Exp Metastasis. 2004;21(8):685-97.

PMID:
16035613
45.

Differential gene expression in liposarcoma, lipoma, and adipose tissue.

Skubitz KM, Cheng EY, Clohisy DR, Thompson RC, Skubitz AP.

Cancer Invest. 2005;23(2):105-18.

PMID:
15813502
46.

Gene expression in giant-cell tumors.

Skubitz KM, Cheng EY, Clohisy DR, Thompson RC, Skubitz AP.

J Lab Clin Med. 2004 Oct;144(4):193-200.

PMID:
15514587
47.

Characterization of sarcomas by means of gene expression.

Skubitz KM, Skubitz AP.

J Lab Clin Med. 2004 Aug;144(2):78-91.

PMID:
15322502
48.

Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Hibbs K, Skubitz KM, Pambuccian SE, Casey RC, Burleson KM, Oegema TR Jr, Thiele JJ, Grindle SM, Bliss RL, Skubitz AP.

Am J Pathol. 2004 Aug;165(2):397-414.

49.

Role of gene expression arrays in sarcomas.

Skubitz KM, Skubitz AP.

Curr Oncol Rep. 2004 Jul;6(4):309-14. Review.

PMID:
15161587
50.

Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.

Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP.

Gynecol Oncol. 2004 Apr;93(1):170-81.

PMID:
15047232

Supplemental Content

Loading ...
Support Center